top of page

Welcome to EMERGE study

Examining Migration and the Epidemiology of Resistance in Groups in Europe

EMERGE research project aims to generate new evidence on antimicrobial resistance in migrant populations at individual, health systems, and pan-European levels to reduce poor health outcomes and protect public health

CHALLENGE

  • Antimicrobial resistance (AMR) occurs when bacteria evolve and no longer respond to antibiotics. As a result, antibiotics may become ineffective, making infection treatment difficult or impossible.

  • ​According to WHO, AMR is one of the 10 global public health threats facing humanity.

  • ​There is insufficient evidence on antibiotic use or treatment barriers across diverse migrant groups to inform the development or prioritisation of AMR infection control and prevention initiatives or surveillance across migration trajectories in Europe.

​

​

CHALLENGES

SOLUTION

To address this knowledge gap in our understanding, the EMERGE project will use a mixed-methods ecological approach to generate novel evidence on AMR patterns in migrant populations at different levels.

​

SOLUTION
PHOTOVOICE
Both flavors of RED Monstro 8K were demoed for us in our studio this week. With a 35_edite

A picture is worth a thousand words

Share your experience with the PhotoVoice project 

The EMERGE project will generate new evidence on AMR in migrants at the individual, health-care system, and transnational levels.

This research will use interdisciplinary and innovative approaches to provide solid evidence on patterns of AMR in migrants to Europe in order to reduce morbidity and mortality, and strengthen the global response to AMR

OUTCOME

OUTCOME

Learn more about AMR

Dr Marie-Paule Kieny, Assistant Director-General for Health Systems and Innovation, and Dr Keiji Fukuda, Special Representative for Antimicrobial Resistance, talk about antimicrobial resistance (AMR)—what it is, why you should be concerned, and what you can do about it.

LEARN MORE
bottom of page